Stressor-induced alterations in immune response and viral clearance following infection with herpes simplex virus-type 1 in BALB/c and C57B1/6 mice

Brain, Behavior, and Immunity

Volumn 11, Issue 1, 1997, Pages 9-23

  Brenner, Gary J ^a   Moynihan, Jan A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031105159     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1997.0480     Document Type: Article

References (30)

1. Blankenhorn, D. H., Azen, S. P., et al. (1993). Coronary angiographic changes with lovastatin therapy: The monitored atherosclerosis regression study (MARS). Ann. Intern. Med. 119, 969-976.
2. Bonneau, R. H., Sheridan, J. F., Feng, N., & Glaser, R. (1991a). Stress-induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection. Brain Behav. Immun. 5, 170-192.
3. Bonneau, R. H., Sheridan, J. F., Feng, N., & Glaser, R. (1991b). Stress-induced effects on cell-mediated and adaptive memory components of the murine immune response to herpes simplex virus. Brain Behav. Immun. 5, 274-295.
4. Brenner, G. J., Cohen, N., & Moynihan, J. A. (1994). Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57B1/6) strains of mice. Cell. Immunol. 157, 510-524.
5. Bretscher, P. A., Wei, G., Menjon, J. N., & Bielefeldt-Ohmann, H. (1992). Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 257, 539-542.
6. Brown, G., Albers, J. J., et al. (1990). Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med. 323, 1289-1298.
7. Cocke, R., Moynihan, J. A., Cohen, N., Grota, L. J., & Ader, R. (1993). Exposure to conspecific alarm chemosignals alters immune responses in BALB/c mice. Brain Behav. Immun. 4, 36-46.
8. Golding, B., Zaitseva, M., & Golding, H. (1994). The potential for recruiting immune responses toward type 1 or type 2 T cell help. Am. J. Trop. Med. Hyg. 50 Suppl., 33-40.
9. Grau, G. E., & Modlin, R. L. (1991). Immune mechanisms in bacterial and parasitic diseases: Protective immunity versus pathology. Curr. Opin. Immunol. 3, 480-485.
10. Karp, J. D., Cohen, N., & Moynihan, J. A. (1994). Effects of differential housing on cytokine production. Life Sci. 55, 789-795.
11. Kastrukoff, L. F., Lau, A. S., & Puterman, M. L. (1986). Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice. J. Gen. Virol. 67, 613-621.
12. Kelso, A. (1995). Th1 and Th2 subsets: Paradigms lost? Immunol. Today 16, 374-379.
13. Kielty, D., Cousins, S. W., & Atherton, S. S. (1987). HSV-1 retinitis and delayed hypersensitivity in DBA/ 2 and C57B1/6 mice. Invest. Opthomol. Clin. Sci. 28, 1994-1991.
14. Kohl, S. (1992). The role of antibody in herpes simplex virus infection in humans. In B. T. Rouse (Ed.), Current Topics in Microbiology and Immunology, Vol. 179, Herpes Simplex Virus Pathogenesis, Immunobiology, and Control, pp. 75-88. Springer-Verlag, Berlin.
15. Kusnecov, A. V., Grota, L. J., Schmidt, S. G., Bonneau, R. H., Sheridan, J. F., Glaser, R., &Moynihan, J. A. (1992). Decreased herpes simplex viral immunity and enhanced pathogenesis following Stressor administration in mice. J. Neuroimmunol. 38, 129-138.
16. Lopez, C. (1975). Genetics of natural resistance to herpesvirus infection in mice. Nature 258, 152-153.
17. Lopez, C. (1980). Resistance to HSV-1 in the mouse is governed by two major, independently segregating, non-H-2 loci. Immunogenetics 11, 87-92.
18. Lopez, C. (1981). Resistance to herpes simplex virus-type 1 (HSV-1). Curr. Top. Microbiol. Immunol. 92, 15-24.
19. Mosmann, T. R., & Fong, T. A. T. (1989). Specific assays for cytokine production by T cells. J. Immunol. Methods 116, 151-158.
20. Moynihan, J. A., & Cohen, N. (1989). The kinetics of recovery of leukocyte number and lymphocyte function following an injection of a single high dose of cyclophosphamide in C3H/HeJ mice. Int. J. Immunopharmacol. 11, 517-527.
21. Moynihan, J. A., Karp, J. D., Cohen, N., & Cocke, R. (1994). Differential effects of stress pheromones on cytokine production and immunity: Possible role of glucocorticoids. J. Neuroimmunol. 54, 51-58.
22. Paul, W. E., & Seder, R. A. (1994). Lymphocyte responses and cytokines. Cell 76, 241-251.
23. Rasmussen, A. F., Jr., Marsh, J. T., & Brill, N. Q. (1957). Increased susceptibility to herpes simplex in mice subjected to avoidance-learning stress or restraint. Proc. Soc. Exp. Biol. Med. 96, 183-189.
24. Romangnani, S. (1994). Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12, 227-257.
25. Schmid, D. S., & Rouse, B. T. (1992). The role of T cell immunity in control of herpes simplex virus. In B. T. Rouse (Ed.), Current Topics in Microbiology and Immunology, Vol. 179, Herpes Simplex Virus Pathogenesis, Immunobiology, and Control, pp. 57-74. Springer-Verlag, Berlin.
26. + T helper cell subsets. Curr. Opin. Immunol. 5, 391-397.
27. Simmons, A., & Nash, A. A. (1987). Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J. Infect. Dis. 155(4), 649-654.
28. Simmons, A., Tscharke, D., & Speck, P. (1992). The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. In B. T. Rouse (Ed.), Current Topics in Microbiology and Immunology, Vol. 179, Herpes Simplex Virus Pathogenesis, Immunobiology, and Control, pp. 32-56. Springer-Verlag, Berlin.
29. Street, N. E., & Mosmann, T. R. (1991). Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5, 171-177.
30. Waters, D., Higginson, L., et al. (1994). Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. Circulation 89, 959-968.